Research graph
References from Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non–small cell lung cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Surgical multimodality treatment for baseline resectable stage IIIA-N2 non–small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival
10.1016/j.ejcts.2009.04.013 · 2009 · External reference
Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group
10.1200/jco.2007.13.9030 · 2008 · External reference
Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group
10.1016/s0140-6736(98)06341-7 · 1998 · External reference
Modern post-operative radiotherapy for stage III non–small cell lung cancer may improve local control and survival: A meta-analysis
10.1016/j.radonc.2013.08.011 · 2014 · External reference
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non–small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial
10.1016/s1470-2045(06)70804-x · 2006 · External reference
10.1016/j.ijrobp.2008.01.044
10.1016/j.ijrobp.2008.01.044 · 2008 · External reference
Postoperative radiotherapy for stage II or III non–small-cell lung cancer using the surveillance, epidemiology, and end results database
10.1200/jco.2005.04.6110 · 2006 · External reference
Postoperative radiotherapy for pathologic N2 non–small-cell lung cancer treated with adjuvant chemotherapy: A review of the National Cancer Data Base
10.1200/jco.2014.58.5380 · 2015 · External reference
Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non–small cell lung cancer: an early closed randomized controlled trial
10.1016/j.radonc.2013.10.008 · 2014 · External reference
Unresolved reference
External reference
Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: Analysis of an international contouring study
10.1016/j.ijrobp.2009.02.072 · 2010 · External reference
Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non–small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group–RTOG 9705
10.1200/jco.2005.12.120 · 2005 · External reference
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
10.1016/s0360-3016(99)00183-2 · 1999 · External reference
The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement
10.1002/(sici)1097-0142(19971015)80:8<1399::aid-cncr6>3.0.co;2-a · 1997 · External reference
Stage IIIA non–small cell lung cancer: Morbidity and mortality of three distinct multimodality regimens
10.1016/j.athoracsur.2013.02.041 · 2013 · External reference
Role of postoperative radiotherapy in resected non-small cell lung cancer: A reassessment based on new data
10.1634/theoncologist.2010-0150 · 2011 · External reference
Postoperative radiation therapy is associated with improved overall survival in incompletely resected stage II and III non–small-cell lung cancer
10.1200/jco.2015.61.1517 · 2015 · External reference
Nodal stage of surgically resected non–small cell lung cancer and its effect on recurrence patterns and overall survival
10.1016/j.ijrobp.2014.12.028 · 2015 · External reference
